CLINICAL_TRIALS
trial_result
· 2020-03-17
Clinical Trial Update: Safety Study of Abatacept to Treat Refractory Sarcoidosis [Phase 2]
Summary
Phase II safety study of abatacept for refractory sarcoidosis was terminated; results posted but no new efficacy data highlighted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Chicago | Conditions: Sarcoidosis | Phase 2 | Status: TERMINATED | Results posted: 2020-03-17